Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Mladkova, Jana ^a   Sanda, Miloslav ^a   Matouskova, Eva ^b   Selicharova, Irena ^a  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BINDING PROTEIN; CARBONYL REDUCTASE; ELONGATION FACTOR 1; ELONGATION FACTOR 1BETA; ELONGATION FACTOR 1GAMMA; GLUTATHIONE BINDING PROTEIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; ALCOHOL DEHYDROGENASE; ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; CBR1 PROTEIN, HUMAN; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; GSTP1 PROTEIN, HUMAN; OXALIPLATIN; PACLITAXEL; PLATINUM COMPLEX;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; PHENOTYPE; PLEURA EFFUSION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; XENOBIOTIC METABOLISM; ADULT; AGED; BREAST TUMOR; CASE CONTROL STUDY; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; HEAD AND NECK TUMOR; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NEUROPHYSIOLOGY; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADULT; AGED; ALCOHOL OXIDOREDUCTASES; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARBOPLATIN; CASE-CONTROL STUDIES; CHROMATOGRAPHY, AFFINITY; CISPLATIN; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; FLUOROURACIL; GLUTATHIONE S-TRANSFERASE PI; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROPHYSIOLOGY; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; PHENOTYPE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77955803289     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-449     Document Type: Article

References (46)

1. Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004, 83:249-289. 10.1023/B:BREA.0000014042.54925.cc, 14758095.
2. Burdall SE, Hanby AM, Lansdown MRJ, Speirs V. Breast cancer cell lines: friend or foe?. Breast Cancer Res 2003, 5:89-95. 10.1186/bcr577, 154155, 12631387.
3. Patterson SD, Aebersold RH. Proteomics: the first decade and beyond. Nature Genet 2003, 33:311-323. 10.1038/ng1106, 12610541.
4. Slany A, Haudek VJ, Zwickl H, Gundacker NC, Grusch M, Weiss TS, Seir K, Rodgarkia-Dara C, Hellerbrand C, Gerner C. Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. J Proteome Res 2010, 9:6-21. 10.1021/pr900057t, 19678649.
5. Hathout Y, Gehrmann ML, Chertov A, Fenselau C. Proteomic phenotyping: metastatic and invasive breast cancer. Cancer Lett 2004, 210:245-253. 10.1016/j.canlet.2004.01.019, 15183541.
6. Gorg A, Drews O, Luck C, Weiland F, Weiss W. 2-DE with IPGs. Electrophoresis 2009, 30(Suppl 1):S122-S132.
7. Weiss W, Gorg A. High-resolution two-dimensional electrophoresis. Methods Mol Biol 2009, 564:13-32. full_text, 19544015.
8. Zuo X, Echan L, Hembach P, Tang HY, Speicher KD, Santoli D, Speicher DW. Towards global analysis of mammalian proteomes using sample prefractionation prior to narrow pH range two-dimensional gels and using one-dimensional gels for insoluble and large proteins. Electrophoresis 2001, 22:1603-1615. 10.1002/1522-2683(200105)22:9<1603::AID-ELPS1603>3.0.CO;2-I, 11425216.
9. Lee WC, Lee KH. Applications of affinity chromatography in proteomics. Anal Biochem 2004, 324:1-10. 10.1016/j.ab.2003.08.031, 14654038.
10. Collinsova M, Castro C, Garrow TA, Yiotakis A, Dive V, Jiracek J. Combining combinatorial chemistry and affinity chromatography: highly selective inhibitors of human betaine: homocysteine S-methyltransferase. Chem Biol 2003, 10:113-122. 10.1016/S1074-5521(03)00008-5, 12618183.
11. Di Pietro G, Magno LA, Rios-Santos F. Glutathione S-transferases: an overview in cancer research. Expert Opin Drug Metab Toxicol 2010, 6:153-170. 10.1517/17425250903427980, 20078251.
12. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009, 390:191-214. 10.1515/BC.2009.033, 2756154, 19166318.
13. Marahatta SB, Punyarit P, Bhudisawasdi V, Paupairoj A, Wongkham S, Petmitr S. Polymorphism of glutathione S-transferase omega gene and risk of cancer. Cancer Lett 2006, 236:276-281. 10.1016/j.canlet.2005.05.020, 15992993.
14. Buser K, Joncourt F, Altermatt HJ, Bacchi M, Oberli A, Cerny T. Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Ann Oncol 1997, 8:335-341. 10.1023/A:1008202723066, 9209662.
15. Chekhun VF, Zhylchuk VE, Lukyanova NY, Vorontsova AL, Kudryavets YI. Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients. Exp Oncol 2009, 31:123-124.
16. Mahajan S, Atkins WM. The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases. Cell Mol Life Sci 2005, 62:1221-1233. 10.1007/s00018-005-4524-6, 15798895.
17. Soule HD, Vazguez J, Long A, Albert S, Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973, 51:1409-1416.
18. Cailleau R, Young R, Olive M, Reeves WJ. Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 1974, 53:661-674.
19. Horie K, Urano T, Ikeda K, Inoue S. Estrogen-responsive RING finger protein controls breast cancer growth. J Steroid Biochem Mol Biol 2003, 85:101-104. 10.1016/S0960-0760(03)00209-7, 12943693.
20. Rochefort H, Glondu M, Sahla ME, Platet N, Garcia M. How to target estrogen receptor-negative breast cancer?. Endocrine-Related Cancer 2003, 10:261-266. 10.1677/erc.0.0100261, 12790787.
21. Tomlinson GE, Chen TTL, Stastny VA, Virmani AK, Spillman MA, Tonk V, Blum JL, Schneider NR, Wistuba II, Shay JW, Minna JD, Gazdar AF. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 1998, 58:3237-3242.
22. Brozova M, Kleibl Z, Netikova I, Sevcik J, Scholzova E, Brezinova J, Chaloupkova A, Vesely P, Dundr P, Zadinova M, Krasna L, Matouskova E. Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors. Breast Cancer Res Treat 2006, 103:247-257. 10.1007/s10549-006-9358-x, 17063277.
23. Selicharova I, Smutna K, Sanda M, Ubik K, Matouskova E, Bursikova E, Brozova M, Vydra J, Jiracek J. 2-DE analysis of a new human cell line EM-G3 derived from breast cancer progenitor cells and comparison with normal mammary epithelial cells. Proteomics 2007, 7:1549-1559. 10.1002/pmic.200600907, 17366476.
24. Matouskova E, Dudorkinova D, Krasna L, Vesely P. Temporal in vitro expansion of the luminal lineage of human mammary epithelial cells achieved with the 3T3 feeder layer technique. Breast Cancer Res Treat 2000, 60:241-249. 10.1023/A:1006409605067, 10930112.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254. 10.1016/0003-2697(76)90527-3, 942051.
26. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974, 249:7130-7139.
27. Rabilloud T. A Comparison Between Low Background Silver Diammine and Silver-Nitrate Protein Stains. Electrophoresis 1992, 13:429-439. 10.1002/elps.1150130190, 1425556.
28. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Righetti PG. Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25:1327-1333. 10.1002/elps.200305844, 15174055.
29. Challapalli KK, Zabel C, Schuchhardt J, Kaindl AM, Klose J, Herzel H. High reproducibility of large-gel two-dimensional electrophoresis. Electrophoresis 2004, 25:3040-3047. 10.1002/elps.200405979, 15349946.
30. Williams K, Chubb C, Huberman E, Giometti CS. Analysis of differential protein expression in normal and neoplastic human breast epithelial cell lines. Electrophoresis 1998, 19:333-343. 10.1002/elps.1150190231, 9548300.
31. Vydra J, Selicharova I, Smutna K, Sanda M, Matouskova E, Bursikova E, Prchalova M, Velenska Z, Coufal D, Jiracek J. Two-dimensional electrophoretic comparison of metastatic and non-metastatic human breast tumors using in vitro cultured epithelial cells derived from the cancer tissues. BMC Cancer 2008, 8:107. 10.1186/1471-2407-8-107, 2377273, 18416831.
32. Gilbert L, Elwood LJ, Merino M, Masood S, Barnes R, Steinberg SM, Lazarous DF, Pierce L, d'Angelo T, Moscow JA. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 1993, 11:49-58.
33. Forrester LM, Hayes JD, Millis R, Barnes D, Harris AL, Schlager JJ, Powis G, Wolf CR. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis 1990, 11:2163-2170. 10.1093/carcin/11.12.2163, 2265468.
34. Bateman RL, Rauh D, Tavshanjian B, Shokat KM. Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. J Biol Chem 2008, 283:35756-35762. 10.1074/jbc.M807125200, 2602912, 18826943.
35. Johansson M, Lundberg M. Glutathionylation of beta-actin via a cysteinyl sulfenic acid intermediary. BMC Biochem 2007, 8:26. 10.1186/1471-2091-8-26, 2228301, 18070357.
36. Ejiri S. Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci Biotechnol Biochem 2002, 66:1-21. 10.1271/bbb.66.1, 11866090.
37. Koonin EV, Mushegian AR, Tatusov RL, Altschul SF, Bryant SH, Bork P, Valencia A. Eukaryotic translation elongation factor 1 gamma contains a glutathione transferase domain--study of a diverse, ancient protein superfamily using motif search and structural modeling. Protein Sci 1994, 3:2045-2054. 10.1002/pro.5560031117, 2142650, 7703850.
38. Zhang W, Wang L, Liu Y, Xu J, Zhu G, Cang H, Li X, Bartlam M, Hensley K, Li G, Rao Z, Zhang XC. Structure of human lanthionine synthetase C-like protein 1 and its interaction with Eps8 and glutathione. Genes Dev 2009, 23:1387-1392. 10.1101/gad.1789209, 2701572, 19528316.
39. Chung CH, Kurien BT, Mehta P, Mhatre M, Mou S, Pye QN, Stewart C, West M, Williamson KS, Post J, Liu L, Wang R, Hensley K. Identification of lanthionine synthase C-like protein-1 as a prominent glutathione binding protein expressed in the mammalian central nervous system. Biochemistry 2007, 46:3262-3269. 10.1021/bi061888s, 17305318.
40. Warleta F, Campos M, Allouche Y, Sanchez-Quesada C, Ruiz-Mora J, Beltran G, Gaforio JJ. Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells. Food Chem Toxicol 2010, 48:1092-1100. 10.1016/j.fct.2010.01.031, 20138105.
41. Pichot CS, Hartig SM, Xia L, Arvanitis C, Monisvais D, Lee FY, Frost JA, Corey SJ. Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells. Br J Cancer 2009, 101:38-47. 10.1038/sj.bjc.6605101, 2713704, 19513066.
42. Aroui S, Brahim S, Waard MD, Kenani A. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. Biochem Biophys Res Commun 2010, 391:419-425. 10.1016/j.bbrc.2009.11.073, 19914216.
43. Huang Y, Hager ER, Phillips DL, Dunn VR, Hacker A, Frydman B, Kink JA, Valasinas AL, Reddy VK, Marton LJ, Casero RA, Davidson NE. A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin Cancer Res 2003, 9:2769-2777.
44. Susila A, Chan H, Loh AX, Phang HQ, Wong ET, Tergaonkar V, Koh CG. The POPX2 phosphatase regulates cancer cell motility and invasiveness. Cell Cycle 2010, 9:179-187.
45. Mineva ND, Wang X, Yang S, Ying H, Xiao ZX, Holick MF, Sonenshein GE. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation. J Cell Physiol 2009, 220:593-599. 10.1002/jcp.21765, 19373868.
46. Wilchek M, Miron T, Kohn J. Affinity chromatography. Methods Enzymol 1984, 104:3-55. full_text, 6371446.